LiveData PeriOp Manager Launched in 88 Veterans Affairs Hospitals
DSS Advances OR Efficiency and Patient Access to Surgery Across 85% of VA Medical Centers With LiveData Software DeploymentCAMBRIDGE, Mass.--(BUSINESS...
Year: 2025
Rapid Dose Completes Issuance of Shares as Payment of Directors’ Fees
Burlington, Ontario--(Newsfile Corp. - January 16, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") is pleased to...
ModMed Named Leader in Physician Practice EHR Software for 11 Specialties in 2025 Black Book Awards
TAMPA, FLORIDA / ACCESS Newswire / January 16, 2025 / ModMed continues to dominate the field of physician practice electronic...
Veos Pharmaceuticals Launches ThymoTropin™ to Support Muscle Health and Preservation on Weight Loss and Aging Journeys
Clinically Proven Myostatin-Targeting Formula to Enhance Muscle Growth, Repair, and Endurance MADRID, SPAIN / ACCESS Newswire / January 16, 2025...
Progyny Appoints Healthcare Veteran Debra Morris to Board of Directors
NEW YORK, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building and women’s health...
Autoimmunity BioSolutions to Present at the 2025 Sequire Investor Summit in Puerto Rico
Houston, Texas, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Autoimmunity BioSolutions is proud to announce that it will be presenting at...
PeopleOne Health Appoints Ty Arlint as Chief Revenue Officer
Seasoned healthcare executive to spearhead growth strategies and market expansion as PeopleOne Health brings its innovative value-based care model to...
Metagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones
MGX-001 in Hemophilia A Advances Towards US and Ex-US Regulatory Interactions in 2025 NHP Proof-of-Concept Anticipated for Secreted Protein Deficiency...
Femasys Announces Notice of Allowance for New U.S. Patent Application Covering Use of FemaSeed® for Female Infertility Treatment
FemaSeed® patent application provides additional coverage for Femasys’ therapeutic option for women seeking infertility solution ATLANTA, Jan. 16, 2025 (GLOBE...
FOXO TECHNOLOGIES INC., CONFIRMS DETAILS OF SPECIAL MEETING OF SHAREHOLDERS ON JANUARY 17, 2025.
MINNEAPOLIS, MN, Jan. 16, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company” or “FOXO”), will hold its previously announced...
United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® PSA Screening Test to Detect an Early Sign of Prostate Cancer
- 10-Minute PSA Test for Early Detection of Prostate Specific Antigen (PSA), an Early Warning Sign of Prostate Cancer -...
Carmell Announces Closing of Elevai Skincare Acquisition
PITTSBURGH, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health...
Enrollment Starts in Africa CDC-Led MpOx Therapeutic Study (MOSA)
ADDIS ABABA, Ethiopia and KINSHASA, Democratic Republic of the Congo and WASHINGTON and PARIS, Jan. 16, 2025 (GLOBE NEWSWIRE) --...
Nusano and Atley Solutions in Collaboration to Accelerate Astatine-211 Development
Nusano isotope production to deliver breakthrough, 100X increase in global At-211 supply, and Atley’s radiopharmaceutical manufacturing technology to enable scalable...
Predictive Oncology Announces Planned European Launch of its ChemoFx® Treatment Selection Marker and Tumor Profiling Assay
Initial plans target European clinical trials while providing standard testing to clinicians for individual patients There are an estimated 250,000...
Inteleos Foundation Announces 2025 MedMissions Award to Advance Ultrasound Access in Four Nations
ROCKVILLE, Md., Jan. 16, 2025 (GLOBE NEWSWIRE) -- The Inteleos Foundation, a global health nonprofit organization, has announced the selection...
Palisade Bio Completes All Five SAD Cohorts and Advances to MAD Cohorts of Phase 1a/b Study of PALI-2108 for Treatment of Ulcerative Colitis
Company on track to report topline data in first half of 2025 Positive preliminary data from all five single ascending...
NOTICE TO DISREGARD — King Faisal Specialist Hospital & Research Centre
RIYADH, Saudia Arabia, Jan. 16, 2025 (GLOBE NEWSWIRE) -- We are advised by King Faisal Specialist Hospital & Research Centre that...
Samsung Bioepis Releases First Quarter 2025 US Biosimilar Market Report
Marks the Third Year Since the Launch of the First US Biosimilar Market Report INCHEON, South Korea, Jan. 16, 2025...
Ocugen, Inc. Announces First Patient Dosed in Phase 1 Clinical Trial of OCU200—a Novel Integrin-Targeting Biologic for Diabetic Macular Edema
MALVERN, Pa., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused...